181 related articles for article (PubMed ID: 3007108)
21. Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.
Herbschleb-Voogt E; Scholten JW; Meera Khan P
Hum Genet; 1983; 63(2):121-5. PubMed ID: 6840756
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of nine RFLPs at the adenosine deaminase (ADA) locus.
Tzall S; Ellenbogen A; Eng F; Hirschhorn R
Am J Hum Genet; 1989 Jun; 44(6):864-75. PubMed ID: 2567118
[TBL] [Abstract][Full Text] [Related]
23. The human gene for adenosine deaminase.
Berkvens TM; Valerio D; Duyvesteyn MG; Dekker BM; Weeda G; van der Voorn L; Breukel C; van Ormondt H; Khan PM; van der Eb AJ
Adv Exp Med Biol; 1986; 195 Pt A():211-6. PubMed ID: 3014832
[No Abstract] [Full Text] [Related]
24. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.
Shovlin CL; Simmonds HA; Fairbanks LD; Deacock SJ; Hughes JM; Lechler RI; Webster AD; Sun XM; Webb JC; Soutar AK
J Immunol; 1994 Sep; 153(5):2331-9. PubMed ID: 8051429
[TBL] [Abstract][Full Text] [Related]
25. Hot spot mutations in adenosine deaminase deficiency.
Hirschhorn R; Tzall S; Ellenbogen A
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6171-5. PubMed ID: 2166947
[TBL] [Abstract][Full Text] [Related]
26. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.
Hirschhorn R; Tzall S; Ellenbogen A; Orkin SH
J Clin Invest; 1989 Feb; 83(2):497-501. PubMed ID: 2783588
[TBL] [Abstract][Full Text] [Related]
27. Cloning of human adenosine deaminase cDNA and expression in mouse cells.
Valerio D; McIvor RS; Williams SR; Duyvesteyn MG; van Ormondt H; van der Eb AJ; Martin DW
Gene; 1984 Nov; 31(1-3):147-53. PubMed ID: 6526272
[TBL] [Abstract][Full Text] [Related]
28. Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase- severe combined immunodeficiency.
Hirschhorn R; Nicknam MN; Eng F; Yang DR; Borkowsky W
J Immunol; 1992 Nov; 149(9):3107-12. PubMed ID: 1401934
[TBL] [Abstract][Full Text] [Related]
29. Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.
Berkvens TM; Gerritsen EJ; Oldenburg M; Breukel C; Wijnen JT; van Ormondt H; Vossen JM; van der Eb AJ; Meera Khan P
Nucleic Acids Res; 1987 Nov; 15(22):9365-78. PubMed ID: 3684597
[TBL] [Abstract][Full Text] [Related]
30. Identification of functional murine adenosine deaminase cDNA clones by complementation in Escherichia coli.
Yeung CY; Ingolia DE; Roth DB; Shoemaker C; Al-Ubaidi MR; Yen JY; Ching C; Bobonis C; Kaufman RJ; Kellems RE
J Biol Chem; 1985 Aug; 260(18):10299-307. PubMed ID: 2410423
[TBL] [Abstract][Full Text] [Related]
31. [Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)].
Allepuz Llop N; Pellejá Pellejá J
An Esp Pediatr; 1982 May; 16(5):421-5. PubMed ID: 7114620
[TBL] [Abstract][Full Text] [Related]
32. Adenosine deaminase deficiency.
Hirschhorn R
Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
34. Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.
Hirschhorn R; Beratis N; Rosen FS
Proc Natl Acad Sci U S A; 1976 Jan; 73(1):213-7. PubMed ID: 1061119
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis of adenosine deaminase deficiency.
Markert ML
Immunodeficiency; 1994; 5(2):141-57. PubMed ID: 8032366
[TBL] [Abstract][Full Text] [Related]
36. Prospects for gene therapy for immunodeficiency diseases.
Kantoff PW; Freeman SM; Anderson WF
Annu Rev Immunol; 1988; 6():581-94. PubMed ID: 3289578
[No Abstract] [Full Text] [Related]
37. Genotype is an important determinant of phenotype in adenosine deaminase deficiency.
Hershfield MS
Curr Opin Immunol; 2003 Oct; 15(5):571-7. PubMed ID: 14499267
[TBL] [Abstract][Full Text] [Related]
38. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
Bordignon C; Yu SF; Smith CA; Hantzopoulos P; Ungers GE; Keever CA; O'Reilly RJ; Gilboa E
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6748-52. PubMed ID: 2549545
[TBL] [Abstract][Full Text] [Related]
39. Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe.
Adrian GS; Wiginton DA; Hutton JJ
Hum Genet; 1984; 68(2):169-72. PubMed ID: 6548726
[TBL] [Abstract][Full Text] [Related]
40. Isolation of cDNA clones for human adenosine deaminase.
Valerio D; Duyvesteyn MG; Meera Khan P; Geurts van Kessel A; de Waard A; van der Eb AJ
Gene; 1983 Nov; 25(2-3):231-40. PubMed ID: 6198240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
